Adaptive Biotechnologies (ADPT) Stock Price
$12.61 6.5%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
4 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Adaptive Biotechnologies, AI stock picks, stock alerts and much more.
ADPT AI Stock Analysis
AI stock analysis for ADPT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Adaptive Biotechnologies (ADPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Adaptive Biotechnologies (ADPT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Adaptive Biotechnologies (ADPT), currently trading at $12.61, will... Sign up to access price prediction.
About ADPT
-
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
-
Symbol
ADPT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.9B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
ADPT Alternative Data
Web Traffic
Adaptive Biotechnologies receives an estimated 29559 monthly visitors to adaptivebiotech.com, which is up by 32.4% over the last month.
-
Web Traffic
29559
-
Change from Previous Month
32.4%
-
3 Month Change
9.4%
-
YoY Change
9.4%
Facebook Engagement
Adaptive Biotechnologies has engaged 1 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1
-
Daily Change
0%
-
1 Month Change
50%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
31,675 are following Adaptive Biotechnologies on LinkedIn, up by 1.3% over the last month.
-
LinkedIn Followers
31675
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
2.8%
-
YoY Change
2.8%
Job Postings
Adaptive Biotechnologies currenly has an estimated 9 open job postings, up by 125% over the last month.
-
Job Postings
9
-
Daily Change
0%
-
1 Month Change
125%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Adaptive Biotechnologies has 645 employees, up by 0.2% over the last month.
-
LinkedIn Employees
645
-
Daily Change
0.3%
-
1 Month Change
0.2%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Reddit Mentions
Adaptive Biotechnologies has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Adaptive Biotechnologies has 4,586 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
4586
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Instagram Followers
Adaptive Biotechnologies has 1,199 Instagram Followers on its main Instagram account, down by -0.7% over the last month.
-
Instagram Followers
1199
-
Daily Change
0.2%
-
1 Month Change
0.7%
-
3 Month Change
1.2%
-
YoY Change
1.2%
Business Outlook
According to employee reviews, the business outlook among employees at Adaptive Biotechnologies is 41 out of 100 (neutral).
-
Business Outlook
41
-
Change from Previous Month
0%
-
3 Month Change
13.9%
-
YoY Change
13.9%
News Mentions
Adaptive Biotechnologies was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
ADPT Financials
ADPT Key Metrics
-
Total Revenue
$52.4M
-
Net Income
-$29.9M
-
Earnings per Share
-$0.2
-
Free cash flow
-$29.7M
-
EBITDA
-$29.6M
-
EBITDA Ratio
-0.564499
-
Total Assets
$510.9M
ADPT 2-year Revenue & Income
ADPT 2-year Free Cash Flow
ADPT Technicals
ADPT SMA
ADPT RSI
FAQ
What's the current price of Adaptive Biotechnologies (ADPT) Stock?
The price of an Adaptive Biotechnologies (ADPT) share is $12.61.
What's the market cap of Adaptive Biotechnologies?
The current market cap of Adaptive Biotechnologies is 1.9B.
What are some stocks similar to Adaptive Biotechnologies (ADPT) that investors often compare it to?
Adaptive Biotechnologies (ADPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Adaptive Biotechnologies' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Adaptive Biotechnologies' stock price to be around $12.56 in 2026. Starting from the current price of $12.61, this represents a 0.4% change in price, indicating a neutral outlook for the stock.
How to buy Adaptive Biotechnologies (ADPT) Stock?
Adaptive Biotechnologies stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Adaptive Biotechnologies shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.